Kezar Life Sciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -1455%. Total operating expenses were $118,424,000.
Profit Margin
| 2016 | 0 | -8.99M | |
|---|---|---|---|
| 2017 | 0 | -8.51M | |
| 2018 | 0 | -23.16M | |
| 2019 | 0 | -31.53M | |
| 2020 | 0 | -38.99M | |
| 2021 | 0 | -53.27M | |
| 2022 | 0 | -65.31M | |
| 2023 | 7M | -101.87M | -1455.29% |
KZR Income Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.06M | 1.02M | 1.51M | 1.54M | 1.30M | 0 | 175K | 0 |
Gross profit | 5.93M | -1.02M | -1.51M | -1.54M | -1.30M | 0 | -175K | 0 |
Operating exp. | ||||||||
Research and development | 85.69M | 51.00M | 38.93M | 30.98M | 27.36M | 18.13M | 6.46M | 7.37M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 118.42M | 71.16M | 54.65M | 42.95M | 37.34M | 24.72M | 8.74M | 8.99M |
Operating income | -105.23M | -71.16M | -54.65M | -42.95M | -37.34M | -24.72M | -8.74M | -8.99M |
Other income (expenses), net | 3.36M | 2.92M | 29K | 1.20M | 2.25M | 1.55M | 232K | 0 |
Income before tax | -101.87M | -68.23M | -54.63M | -41.74M | -35.08M | -23.16M | -8.51M | -8.99M |
Income tax expense | 0 | -2.92M | -1.35M | -2.75M | -3.55M | 1.55M | 0 | 0 |
Net income | -101.87M | -65.31M | -53.27M | -38.99M | -31.53M | -23.16M | -8.51M | -8.99M |
Earnings per share | ||||||||
Basic EPS | -1.4 | -0.97 | -1.01 | -0.89 | -1.65 | -2.26 | -0.65 | -0.69 |
Diluted EPS | -1.4 | -0.97 | -1.01 | -0.89 | -1.65 | -2.26 | -0.65 | -0.69 |
| Data source | Data source | Data source | Data source | Data source | Data source |